Pharm Exec's latest annual listing of the top biopharma players paints a stable picture of performance for the usual placeholders, but change and disruption to current business models could upend positioning in the years ahead.
Milestone on Bayer’s path to completing the planned acquisition of Monsanto
A new method allows the design and construction of nanometric cages using proteins. The structures are able to self-assemble inside cells and living beings. This protein “origami” could have applications in the development of new methods for administering drugs, vaccines, or molecular machines
Ajudge on Friday tossed out a $417-million jury award to a woman who claimed she developed ovarian cancer by using Johnson & Johnson’s talc-based baby powder for feminine hygiene.